Concepedia

Ludmyla Rekeda

LR

Statistics

Publications

15

Citations

1.4K

H-Index

15

Active since

2005

Affiliations

Allergan (United States)(Current)

Almirall (Spain)

Novartis (Switzerland)

Novartis (United States)

University of Nebraska Medical Center

Ludmyla Rekeda is an author at Allergan (United States) specializing in pharmacotherapy, medicine, and clinical pharmacology.

Publications per year

2005–2023

15

Publications

15

Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects

Gary G. Kay, Thomas H. Crook, Ludmyla Rekeda et al. · European Urology · 2006 · 302 citations

, , +9

Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

Willie Earley, Maria Victoria Burgess, Barbara Khan et al. · Bipolar Disorders · 2019 · 245 citations · Full text

, , +16

Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study

Willie Earley, Maria Victoria Burgess, Ludmyla Rekeda et al. · American Journal of Psychiatry · 2019 · 155 citations · Full text

, , +17

Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND): A Randomized Clinical Trial

Fernando J. Martínez, Klaus F. Rabe, Sanjay Sethi et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 125 citations

, , +17

Darifenacin treatment of patients ≥ 65 years with overactive bladder: results of a randomized, controlled, 12-week trial

Christopher R. Chapple, Catherine E. DuBeau, Ursula Ebinger et al. · Current Medical Research and Opinion · 2007 · 91 citations

, , +16

1–5 of 15